Browsing Tag
Volt
2 posts
Heart ablation is moving beyond heat and cold, and the medtech race is getting much bigger
Pulsed field ablation is changing atrial fibrillation treatment by using extremely short electrical pulses to disrupt targeted cardiac cells instead of relying primarily on heat or freezing. Boston Scientific, Medtronic, Abbott Laboratories and Johnson & Johnson now compete across multiple FDA-approved PFA platforms, while new trials are pushing the technology into persistent atrial fibrillation, broader lesion sets and potentially earlier treatment.
Abbott (ABT) stock surges 12% as Q2 earnings beat lifts 2026 EPS outlook to $5.45-$5.60
Abbott shares headed for their strongest daily gain in 24 years after the healthcare group beat second-quarter expectations and raised its adjusted earnings forecast.